top of page

Explore our science and technology through peer-reviewed publications with our academic collaborators

Genotoxicity assessment of 1,4-anhydro-4-seleno-D-talitol (SeTal) in human liver HepG2 and HepaRG cells. Toxicology 2023, 499, 153663.

Treating atopic-dermatitis-like skin lesions in mice with gelatin-alginate films containing 1,4-anhydro-4-seleno-D-talitol (SeTal). Int. J. Pharm. 2023, 642, 123174.

The quest for selenocycles: From an ESR spectrum to a commercial product. J. Chem. Res. 2022, 46, 17475198221089514.

Suppressive effect of 1,4-anhydro-4-seleno-D-talitol (SeTal) on atopic dermatitis-like skin lesions in mice through regulation of inflammatory mediators. J. Trace Elem. Med. Biol. 2021, 67, 126795.

1,4-Anhydro-4-seleno-D-talitol (SeTal): a remarkable selenium-containing therapeutic molecule. New J. Chem. 2019, 43, 9759.

Synthesis and antioxidant capacity of novel stable 5-tellurofuranose derivatives. Chem. Commun. 2018, 54, 2990.

1,4-Anhydro-4-seleno-D-talitol (SeTal) protects endothelial function in the mouse aorta by scavenging superoxide radicals under conditions of acute oxidative stress. Biochem. Pharmacol. 2017, 128, 34.

Reaction of Selenium Compounds with Reactive Oxygen Species and the Control of Oxidative Stress, in Organoselenium Compounds in Biology and Medicine. pp 254-276, Royal Society of Chemistry (2017).

bottom of page